Hangzhou Grand Pharmaceutical

Hangzhou Grand Pharmaceutical is a prominent Chinese pharmaceutical company and a core subsidiary of the Grand Pharmaceutical Group. The company specializes in the development, production, and sale of high-quality pharmaceutical preparations and active pharmaceutical ingredients (APIs), with a strong focus on cerebro-cardiovascular emergency medicine, ophthalmology, and otorhinolaryngology. It is one of the largest production bases for adrenaline-series products globally and maintains a significant presence in the domestic Chinese market. Hangzhou Grand is committed to innovation, leveraging its R&D capabilities to expand its portfolio into advanced therapeutic areas such as oncology and precision interventional medicine. The company's manufacturing facilities are GMP-certified, ensuring compliance with international quality standards for its diverse product line.